Kaiser评分在对比增强乳腺摄影评估乳腺病变中的诊断效能
结果显示KS的AUC为0.915和0.876,高于BI-RADS的0.821–0.842,特异度显著提升,并可减少41.7%–47.9%的良性病变不必要的活检。
要点
- KS在CEM上鉴别乳腺良恶性病变的AUC高于BI-RADS,特异度显著更优。
- KS对肿块型病变的诊断效能优于非肿块强化(NME)。
- 应用KS可潜在减少41.7%–47.9%良性病变的不必要活检。
核心结论
- KS在CEM上区分乳腺良恶性病变具有高诊断效能,且优于BI-RADS。
- 应用KS可将高达47.9%的良性乳腺病变不必要的活检降级。
研究设计与样本
- 两位不同经验水平的乳腺影像阅片者分别给出CEM BI-RADS分类和KS评分。
- 采用ROC分析评估全部病变、肿块和非肿块强化(NME)的诊断效能,计算AUC和加权kappa系数。
诊断标准与关键数值
- KS对全部病变的AUC为0.915(95%CI: 0.884–0.947)和0.876(95%CI: 0.838–0.914)(两位读者)。
- BI-RADS对全部病变的AUC范围为0.821(95%CI: 0.778–0.864)至0.842(95%CI: 0.801–0.883)。
- KS的AUC高于BI-RADS(p<0.001, p=0.016)。
- KS与BI-RADS的敏感度分别为97.4%和99.6%,无显著差异(p=0.130);KS特异度显著高于BI-RADS(p<0.001)。
- 两位读者间KS评分一致性几乎完美(k=0.883,95%CI: 0.842–0.924)。
临床应用与阅片要点
- 在CEM阅片中对强化病变应用KS评分,可提高诊断特异度并减少良性病变的活检。
- KS对肿块型病变的诊断效能优于NME,判读NME时需谨慎。
- KS评分在不同经验读者间一致性高,适合作为结构化报告辅助工具。
局限性
- 回顾性单中心研究设计。
- 样本中恶性病变占多数(231/375),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to investigate whether the Kaiser score (KS) could improve the diagnostic performance of breast imaging reporting and data system (BI-RADS) in evaluating breast enhancing lesions on contrast-enhanced mammography (CEM).
METHODS: Three hundred fifty-nine patients with 375 lesions (231 malignant and 144 benign) were included in this retrospective study from April 2019 to December 2021.Two readers with different levels of experience in breast imaging were asked to give a BI-RADS assessment category according to the CEM BI-RADS and final score based on the KS. The diagnostic performance of all lesions, mass and non-mass enhancement (NME) were assessed by receiver operating characteristic (ROC) analysis, and the areas under the ROC curve (AUCs) were measured. The weighted kappa coefficients were calculated to investigate the interreader agreement.
RESULTS: The AUCs of the KS for all lesions were 0.915 (95 %CI: 0.884-0.947) and 0.876 (95 %CI: 0.838-0.914) for two readers. When mass and NME were evaluated separately, the AUCs of the KS for mass were higher than those for NME (p < 0.001). The AUCs of BI-RADS for all lesion diagnoses ranged between 0.821 (95 %CI: 0.778-0.864) and 0.842(95 %CI: 0.801-0.883) for two readers. The AUCs of the KS were higher than those of BI-RADS (p < 0.001, p = 0.016). There were no significant differences in the sensitivity between the KS (97.4 %) and BI-RADS (99.6 %) for all lesions (p = 0.130). The specificity of the KS was significantly higher than that of BI-RADS (p < 0.001). Compared with BI-RADS, the application of the KS could have potentially obviated 41.7 % to 47.9 % unnecessary biopsies in 144 benign lesions. Interreader agreement between the two readers of the KS was almost perfect (k = 0.883 [95 % CI: 0.842-0.924]).
CONCLUSION: The use of the KS provided a high diagnostic performance in distinguishing malignant and benign breast lesions on CEM and outperformed BI-RADS. The application of the KS can downgrade up to 47.9% of unnecessary biopsies of benign breast lesions.
引用
- Kang, Li, Yang, et al. Diagnostic performance of the Kaiser score in the evaluation of breast lesions on contrast-enhanced mammography. Eur J Radiol. 2022. PMID: 36126352. doi:10.1016/j.ejrad.2022.110524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。